AzTrials
AzTrials

Occlusal CariesNCT06260644

Evaluation of Using Self-adhering Flowable Resin Composite in Repairing Old Defective Resin Composite Restorations Over 18 Months Follow up. (A Randomized Clinical Trial)

A study testing VertiseTM flowable composite (Kerr,USA) in people with Occlusal Caries, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This research proposal is evaluating the clinical performance of using self-adhering flowable resin composite in repairing old occlusal defective resin composite versus conventional flowable resin composite restoration over 18 months. Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Occlusal Caries
What is being tested?
VertiseTM flowable composite (Kerr,USA)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteEgypt
Study dates
1 Feb 2024to Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients (18-35 y)
  • patients with defective resin composite class I restorations that need repair.
  • dental motivated patients who attends regularly.
  • Vital posterior teeth with repairable defective resin composite class I restorations.
  • Localized marginal defect or marginal staining FDI 3\& 4.
  • Teeth with no or minimum mobility \& healthy peridontium.
  • No history of any irreversible pulpal pain or necrosis in the teeth to be restored.

Who cannot join

  • • Patients with defective restorations that dictate replacement
  • Uncooperative behavior limits the isolation techniques throughout the procedure.
  • Presence of parafunctional habits.
  • Patient with history of systemic medical disease, or any other serious relevant problem.
  • High caries risk patients. Periodontal disease that may affect the prognosis of the restoration or the tooth itself.
  • Fractured or visibly cracked teeth.
  • Symptoms of any pulp pathosis.
  • Defective resin composite restorations that dictate replacement.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry

    Cairo, 113311

Other trials in Egypt

About this study

Official title: Evaluation of Using Self-adhering Flowable Resin Composite Versus Conventional Nano-filled Flowable Resin Composite in Repairing Old Defective Resin Composite Restorations Over 18 Months Follow up. (A Randomized Clinical Trial)

This research proposal is evaluating the clinical performance of using self-adhering flowable resin composite in repairing old occlusal defective resin composite versus conventional flowable resin composite restoration over 18 months.

Conditions
Occlusal Caries
Being tested
VertiseTM flowable composite (Kerr,USA)
Keywords
flowable resin composite

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VertiseTM flowable composite (Kerr,USA)Procedure or surgery

    self adhesive flowable resin composite restoration.

Study groups in NCT06260644
Study groupRoleWhat they receive
Conventional flowable nano filled resin compositeActive comparatorRepairing the old defective class I composite restoration by conventional nano filled flowable resin composite.
Receives: Procedure: VertiseTM flowable composite (Kerr,USA)
Self adhesive flowable resin compositeExperimentalRepairing the old defective class I composite restoration by self adhering flowable resin composite.
Receives: Procedure: VertiseTM flowable composite (Kerr,USA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Restoration clinical performance using FDI criteria

    FDI criteria mechanical parameters

    Measured: assessment will be done after the treatment then 6 months, 12 months and18 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2024
  2. Study start1 Feb 2024
  3. Primary completionSep 2025 (estimated)
  4. Study completionOct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
parallel assignment
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06260644
Sponsor's protocol ID
Repairing defective composite
Status last verified
Feb 2024
First submitted
7 Feb 2024
Last updated
15 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VertiseTM flowable composite (Kerr,USA) in people with Occlusal Caries, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Restoration clinical performance using FDI criteria (time frame: assessment will be done after the treatment then 6 months, 12 months and18 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in